Cases 41 - 50 of 220
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TARO PHARMACEUTICALS U.S.A., INC. et al v. LUPIN LIMITED et al
as 1:2021cv20320
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN ATLANTIS HOLDING SA
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. et al v. Lupin Limited et al
as 1:2021cv01621
Plaintiff:
Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and others
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd. and others
Cause Of Action: 35 U.S.C. § 1
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TARO PHARMACEUTICALS U.S.A., INC. et al v. LUPIN LIMITED et al
as 2:2021cv20320
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN ATLANTIS HOLDING SA
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. et al
as 1:2021cv01486
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Lupin Ltd. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
ViiV Healthcare Company et al v. Lupin Limited et al
as 1:2021cv01561
Plaintiff:
ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01408
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Supernus Pharmaceuticals, Inc. v. Lupin Limited et al
as 1:2021cv01293
Plaintiff:
Supernus Pharmaceuticals, Inc.
Defendant:
Lupin Limited, Lupin Atlantis Holdings S.A., Nanomi B.V. and others
Cause Of Action: 28 U.S.C. § 1338
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
